Latest Myasthenia Gravis news
FDA Approves Zilbrysq for Generalized Myasthenia Gravis
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Thymectomy + PDN Beneficial for Non-Thymomatous Myasthenia Gravis
posted January 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with non-thymomatous myasthenia gravis, thymectomy plus prednisone confers benefits versus prednisone alone at five years, according to a study published online Jan. 25 in The Lancet Neurology.
Editor's Recommendations
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD 
150+ Minutes of Social Media Daily Tied to Depression in Adults 
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Thymectomy Improves Outcomes in Myasthenia Gravis 
Autologous HSCT Can Result in Remission in Myasthenia Gravis Monthly Specialist Briefings
Stay Connected
